Evidence map›Paper›PMID 38672709›Full record

ArticleLife (Basel, Switzerland)2024

Assessment of the Tolerance of Dobenox Forte

Jerzy Chudek, Agnieszka Almgren-Rachtan, Agnieszka Pastuszka, Damian Ziaja

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Jerzy ChudekDepartment of Internal Medicine and Oncological Chemotherapy, Medical Faculty in Katowice, Medical University of Silesia in Katowice, 40-027 Katowice, Poland.ORCID 0000-0002-6367-7794
Agnieszka Almgren-RachtanDepartment of Pharmacovigilance, Europharma Research & Scientific Centre Co., Ltd., 40-061 Katowice, Poland.ORCID 0000-0002-6766-8123
Agnieszka PastuszkaDepartment of Pharmacovigilance, Europharma Research & Scientific Centre Co., Ltd., 40-061 Katowice, Poland.ORCID 0000-0001-7608-8414
Damian ZiajaDepartment of Physiotherapy, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland.
Medical University of Silesia · PL

Funding

Hasco-Lek Co. Ltd. Has/Dob/2016/006
6 · The paper itself

Abstract

This prospective, observational, multicenter study assessed the tolerance of Dobenox Forte

Indexed as

calcium dobesilatecalf circumferencecalf crampschronic venous diseaselimb heavinesslower legs swelling

Identifiers

PMID38672709
PMCPMC11051120
OpenAlexW4393189387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.